Introduction: Autoimmune diabetes has different clinical manifestations related to the age at onset. It is divided into several subtypes, including "classical" type 1 diabetes (T1D) and latent autoimmune diabetes in adults (LADA). The LADA is considered a slowly progressing subtype of autoimmune diabetes, although the clinical picture is more similar to type 2 diabetes. Material and methods: The aim of this study is to investigate whether genetic predisposition influences age at onset in autoimmune diabetes. We studied rs2476601 PTPN22 gene polymorphism and HLA DR, HLA-DQB1 in 175 patients with classical type 1 diabetes, 80 LADA, and 151 control subjects from northeast Poland. Results: The frequencies of the PTPN22 TT genotype were higher in the group of patients with classical type 1 diabetes (6.3%) and LADA (11.3%) than in control subjects (0.7%) (p = 0.02 and p = 0007, respectively). In patients with classical type 1 diabetes we observed an increasing trend in frequencies of genotype TT dependent on age at onset (3.9% (0-5 year olds), 6.0% (6-15 year-olds), 8.2% (16-25 year olds), p = 0.048). The incidence of predisposing human leukocyte antigen (HLA) genotypes HLA DR3/DQB1*02 and DR4/DQB1*0302 was found to decrease in the group with type 1 diabetes in relation to age at onset and LADA (HLA DR3/DQB1*02 -69.2% (0-5 year olds), 57.0% (6-15 year olds), 51.0% (16-25 year olds), 46.3% (LADA), p = 0.032; HLA DR4/DQB1*0302 -80.8% (0-5 year olds), 63.0% (6-15 year olds), 51.0% (16-25 year olds), 43.8% (LADA), p = 0.0003), and to increase for the protective allele DQB1*0602 (0.0% (0-5 year olds), 1.0% (6-15 year olds), 2.0% (16-25 year olds), 6.3% (LADA), p = 0.029). Conclusions: Thus, age at onset for autoimmune diabetes appears to be related to a combination of predisposing and protective HLA alleles. Against a background of HLA genetic predisposition, other non-HLA loci may influence age at onset for late autoimmune diabetes.
Introduction
There are two major clinical manifestations of autoimmune diabetes: type 1 diabetes (T1D) and latent autoimmune diabetes in adults (LADA) [1, 2] . The LADA is characterized by adult onset, no requirement for insulin for several months following diagnosis and presence of islet autoantibodies similar to those found in type 1 diabetes, but with a clinical picture more similar to type 2 diabetes [3] .
Patients with LADA have been found to share similar genetic susceptibility traits with type 1 diabetics. These include (i) protein tyrosine phosphatase non-receptor type 22 (PTPN22) gene polymorphism [4, 5] , (ii) insulin gene variable tandem repeats (INS VNTR) [6] and (iii) HLA locus [7] with more common protective and less frequent predisposing HLA genotypes in LADA than in T1D [5, 8] . Prevalence of LADA and classification criteria have been previously described in the Polish population [9] .
Although the role of PTPN22 in predisposition to autoimmune diabetes has previously been described [10] , its role in modifying age at onset in autoimmune diabetes is not fully understood and observations reported to date are contradictory [11] [12] [13] [14] [15] . Therefore, the aim of this study was to evaluate the correlation between genetic predisposition -in terms of PTPN22 polymorphism and HLA genotypes -and age at onset of autoimmune diabetes in two patient populations with different disease manifestations (T1D and LADA).
Material and methods
The study protocol was approved by the Ethics Committee of the Medical Academy in Bialystok. Informed consent was obtained from all patients before blood sampling. Single nucleotide polymorphism genotyping DNA was extracted from peripheral blood leukocytes. Genotyping of the rs2476601 polymorphism of PTPN22 was performed using PCR sequencespecific primers with the ABI Prism 310 genetic analyzer (Applied Biosystems, Stanford, TX). Primer sequences for position -185 were forward 5'-tcaccagcttcctcaaccaca-3' and reverse 5'-gataatgttgcttcaacggaattt-3'. HLA genotyping was performed as previously described [16] .
Statistical analysis
The genotype distribution differences in the population studied were assessed with Haploview v3.2 (http://www.broad.mit.edu/mpg/haploview).
The χ 2 test or Fisher's exact probability test were used to estimate the differences in the distribution of alleles, genotypes, and haplotypes between the studied groups. Trend analysis was performed with the Cochran-Armitage test (SAS/STAT version 9.0 SAS Institute).
Values of p were corrected for the number of different haplotypes tested (Pc). Statistical significance was defined as p < 0.05.
Results
Clinical characteristics of the subjects are presented in Table I . Mean age at diagnosis (± standard deviation (SD)) was 20.9 ±12.5 years for type 1 and 45.4 ±9.6 years for LADA.
PTPN22 in patients with T1D and LADA
All genotypes of the PTPN22 1858T variant were in Hardy-Weinberg equilibrium. Frequencies of allele T and distribution of genotypes CC, CT and TT were similar in patients with T1D and LADA (1858T: 18.9% (T1D) vs. 23.8% (LADA), χ 2 = 1.62, p = 0.20 and CC/CT/TT: 68.6%/25.1%/6.3% (T1D) vs. 63.7%/ 25.0%/11.3% (LADA), χ 2 = 1.91, p = 0.38.
The frequencies of the PTPN22 allele T and genotype TT were higher in the group of patients with T1D than in the controls (18.9% vs. 12.6%, p = 0.03; 6.3% vs. 0.7%, p = 0.02, respectively). Data are presented in Table II . The frequencies of the PTPN22 allele T and genotype TT in the group of patients with LADA were also higher than in controls (23.8% vs. 12.6%, p = 0.002; 11.3% vs. 0.7%, p = 0.0007, respectively) ( Table II) .
Association of PTPN22 with age at onset for T1D
The group of 175 patients with type 1 diabetes was divided according to age of diabetes onset: (Table III) .
Association of HLA with age at onset of autoimmune diabetes (type 1 and LADA)
We investigated the association between the HLA genotypes DR3/DQB1*02 and DR4/DQB1*0302 and increasing risk for T1D, as well as the association between the HLA genotype DQB1*0602 and decreasing risk for T1D in T1D patients (divided into 3 groups according to age at onset) and in LADA patients. As age at onset increased, we observed decreasing frequencies of the predisposing HLA alleles HLA DR3/DQB1*02 (69.2% (T1D 0-5 years), 57.0% (T1D 6-15 years), 51.0% (T1D 16-25 years), 46.3% (LADA), p = 0.032) and DR4/DQB1*0302 (80.8% (T1D 0-5 years), 63.0% (T1D 6-15 years), 51.0% (T1D 16-25 years), 43.8% (LADA), p = 0.0003) and an increased incidence of the protective allele DQB1*0602 (0.0% (T1D 0-5 years), 1.0% (T1D 6-15 years), 2.0% (T1D 16-25 years), 6.3% (LADA), p = 0.029) (Table IV) .
Discussion
Diagnosis of LADA is based on autoimmune status and age at onset [17] . The role that genetic predisposition may play in modifying age at diabetes onset and clinical presentation of autoimmune diabetes is unclear. Previous observations in review articles [18, 19] and recent analysis of siblings affected and not affected by type 1 diabetes [20] showed that age of manifestation of symptoms in T1D is strongly related to HLA genetic predisposition. In our study we have shown that age at onset for [4, 5, 7, 21, 22] showed that patients with LADA had an increased frequency of DQB1*0602, suggesting that the presence of "protective" HLA alleles may have a predominant role in delaying onset of autoimmune diabetes [22] . A predisposing role of PTPN22 gene polymorphism for type 1 diabetes [12, 13, 23, 24] , and also for LADA, was previously described [4, 5] . However, the role of the PTPN22 gene in modifying age at onset for autoimmune diabetes was not clear. In a study conducted by Kordonouri et al. [11] carriers of genotype TT of the PTPN22 gene had an earlier onset of disease compared to patients with the CT and CC genotype, and a similar trend was observed by others [12, 13] . Other studies investigated the role of a predisposing PTPN22 genotype in progression to type 1 diabetes [15] and loss of residual beta cell function [10] . A study performed in the Denver Diabetes Center, however, did not observe an association of the PTPN22 gene predisposing TT genotype with age at onset for patients with type 1 diabetes [14] .
In the present study, the frequency of the PTPN22 gene high-risk genotype TT increased with increasing age at diagnosis for patients with T1D. In addition, the frequency of genotype TT in patients with LADA was twice that of patients with type 1 diabetes. Consistent with previous observations [4, 5, 22] our study revealed the PTPN22 genotype TT to be related to an increased risk for LADA. This observation may suggest that significance of non-HLA related genetic predisposition, in this study PTPN22 genotype TT, may have a significant effect on the age at diagnosis for latent autoimmune diabetes and/or type 1 diabetes in young adults, whereas HLA-related genetic predisposition determined age at onset in children with type 1 diabetes.
In conclusion, age at onset for autoimmune diabetes is linked to a combination of predisposing and protective HLA alleles. Against a background of HLA genetic predisposition, other non-HLA loci may influence age at onset of late autoimmune diabetes and this association may be more significant than in patients with classic type 1 diabetes.
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